New agents for the treatment of cancer‐related fatigue

Existing countermeasures to fatigue, such as exercise, diet, and psychostimulant drugs, are often used but remain unproven in efficacy. Carefully designed trials are necessary to explore the benefits of these and other therapeutic strategies.

Saved in:
Bibliographic Details
Published in:Cancer 2001-09, Vol.92 (S6), p.1714-1718
Main Author: Burks, Thomas F.
Format: Article
Language:English
Subjects:
alpha-MSH - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Biological and medical sciences
Bradykinin - antagonists & inhibitors
Cyclooxygenase 1
Cyclooxygenase 2
Fatigue - drug therapy
Fatigue - etiology
Humans
Isoenzymes - antagonists & inhibitors
Medical sciences
Membrane Proteins
Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
Neoplasms - complications
Pentoxifylline - therapeutic use
Prostaglandin-Endoperoxide Synthases
Tumors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Existing countermeasures to fatigue, such as exercise, diet, and psychostimulant drugs, are often used but remain unproven in efficacy. Carefully designed trials are necessary to explore the benefits of these and other therapeutic strategies.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(20010915)92:6+<1714::AID-CNCR1502>3.0.CO;2-N